Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (131-140 of 1,137) with videos related to

Pageof 114
Sort By:
The American Journal of Cardiology|August 30, 2005
Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?Kausik K Ray, Christopher P Cannon
Current Opinion in Cardiology|October 20, 2005
Optimal goals for statin use in patients with coronary artery diseaseKausik K Ray, Christopher P Cannon
Chest|March 1, 1995
The importance of rapidly treating patients with acute myocardial infarctionC P Cannon, S Z Goldhaber
Lancet (London, England)|June 1, 2017
STREAM characterisation correction - Authors' replyGrant W Reed, Christopher P Cannon
Clinical Cardiology|July 23, 2013
Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stentingGrant W Reed, Christopher P Cannon
Clinical Cardiology|March 8, 2018
PCSK9 inhibitor valuation: A science-based review of the two recent modelsSeth J Baum, Christopher P Cannon
Pediatric Clinics of North America|February 1, 1980
School dysfunction in the adolescentI P Cannon, C L Compton
Circulation|June 2, 2005
Treatment of elevated cholesterolBenjamin M Scirica, Christopher P Cannon
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 10, 2000
Reducing medication errors: potential benefits of bolus thrombolytic agentsC F Richards, C P Cannon
The American Journal of Cardiology|December 25, 2007
Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potentialBenjamin A Steinberg, Christopher P Cannon
Pageof 114

Showing results (131-140 of 1,137) with videos related to

Sort By:
Pageof 114
The American Journal of Cardiology|August 30, 2005
Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?Kausik K Ray, Christopher P Cannon
Current Opinion in Cardiology|October 20, 2005
Optimal goals for statin use in patients with coronary artery diseaseKausik K Ray, Christopher P Cannon
Chest|March 1, 1995
The importance of rapidly treating patients with acute myocardial infarctionC P Cannon, S Z Goldhaber
Lancet (London, England)|June 1, 2017
STREAM characterisation correction - Authors' replyGrant W Reed, Christopher P Cannon
Clinical Cardiology|July 23, 2013
Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stentingGrant W Reed, Christopher P Cannon
Clinical Cardiology|March 8, 2018
PCSK9 inhibitor valuation: A science-based review of the two recent modelsSeth J Baum, Christopher P Cannon
Pediatric Clinics of North America|February 1, 1980
School dysfunction in the adolescentI P Cannon, C L Compton
Circulation|June 2, 2005
Treatment of elevated cholesterolBenjamin M Scirica, Christopher P Cannon
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 10, 2000
Reducing medication errors: potential benefits of bolus thrombolytic agentsC F Richards, C P Cannon
The American Journal of Cardiology|December 25, 2007
Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potentialBenjamin A Steinberg, Christopher P Cannon
Pageof 114